94 related articles for article (PubMed ID: 24402212)
1. Expression of matrix metalloproteinases in patients with bipolar disorder.
Chiarani F; Fries GR; Stertz L; Ceresér KM; Wyse AT; Kapczinski FP; Kunz M
Braz J Psychiatry; 2013; 35(4):375-9. PubMed ID: 24402212
[TBL] [Abstract][Full Text] [Related]
2. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
Dabek J; Glogowska-Ligus J; Szadorska B
J Postgrad Med; 2013; 59(2):115-20. PubMed ID: 23793312
[TBL] [Abstract][Full Text] [Related]
3. Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease.
Gao Q; Meijer MJ; Schlüter UG; van Hogezand RA; van der Zon JM; van den Berg M; van Duijn W; Lamers CB; Verspaget HW
Inflamm Bowel Dis; 2007 Jun; 13(6):693-702. PubMed ID: 17243139
[TBL] [Abstract][Full Text] [Related]
4. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
5. Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Huusko T; Salonurmi T; Taskinen P; Liinamaa J; Juvonen T; Pääkkö P; Savolainen M; Kakko S
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):1117-1123. PubMed ID: 22571802
[TBL] [Abstract][Full Text] [Related]
6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
7. Association of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 With Endothelial Dysfunction, Cardiovascular Disease Risk Factors and thrombotic events in Children With End-stage Renal Disease.
Gheissari A; Meamar R; Abedini A; Roomizadeh P; Shafiei M; Samaninobandegani Z; Tabrizi Z; Mahmoudi F; Merrikhi A; Najafi Tavana E
Iran J Kidney Dis; 2018 May; 12(3):169-177. PubMed ID: 29891747
[TBL] [Abstract][Full Text] [Related]
8. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
Florys B; Głowińska B; Urban M; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
[TBL] [Abstract][Full Text] [Related]
9. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Rybakowski JK; Remlinger-Molenda A; Czech-Kucharska A; Wojcicka M; Michalak M; Losy J
J Affect Disord; 2013 Apr; 146(2):286-9. PubMed ID: 22858217
[TBL] [Abstract][Full Text] [Related]
10. Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis.
Woo M; Patterson EK; Cepinskas G; Clarson C; Omatsu T; Fraser DD
Pediatr Res; 2016 Feb; 79(2):295-300. PubMed ID: 26492282
[TBL] [Abstract][Full Text] [Related]
11. A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Sinha I; Bethi S; Cronin P; Williams DM; Roelofs K; Ailawadi G; Henke PK; Eagleton MJ; Deeb GM; Patel HJ; Berguer R; Stanley JC; Upchurch GR
J Vasc Surg; 2006 Feb; 43(2):342-8. PubMed ID: 16476613
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
[TBL] [Abstract][Full Text] [Related]
13. Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT).
Shibasaki C; Itagaki K; Abe H; Kajitani N; Okada-Tsuchioka M; Takebayashi M
Int J Neuropsychopharmacol; 2018 Mar; 21(3):236-241. PubMed ID: 29025075
[TBL] [Abstract][Full Text] [Related]
14. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
[TBL] [Abstract][Full Text] [Related]
15. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
16. Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis.
Sanchooli J; Ramroodi N; Sanadgol N; Sarabandi V; Ravan H; Rad RS
Kaohsiung J Med Sci; 2014 May; 30(5):235-42. PubMed ID: 24751386
[TBL] [Abstract][Full Text] [Related]
17. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
18. MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD.
Sng JJ; Prazakova S; Thomas PS; Herbert C
COPD; 2017 Apr; 14(2):238-244. PubMed ID: 27880043
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Liu N; Cao Y; Zhu G
Arch Oral Biol; 2017 Mar; 75():62-67. PubMed ID: 28043014
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
